Ken Op de Beeck

Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies

Nele Boeckx, Reija Koukakis, Ken Op de Beeck et al. · Annals of Oncology · 2017 · 219 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein

Ken Op de Beeck, Guy Van Camp, Sofie Thys et al. · European Journal of Human Genetics · 2011 · 133 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1

Timon Vandamme, Marc Peeters, Fadime Dogan et al. · Journal of Molecular Endocrinology · 2015 · 108 citations · Full text

Medicine, Genetics, Oncology +17

Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer

Lieselot Croes, Matthias Beyens, Erik Fransén et al. · Clinical Epigenetics · 2018 · 106 citations · Full text

Medicine, Genetics, Oncology +17

Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells

Katarzyna Szarc vel Szic, Ken Op de Beeck, Dariusz Ratman et al. · PLoS ONE · 2014 · 102 citations · Full text

Medicine, Oncology, Pharmacology +17